Key result
Embolization techniques yield unsatisfactory outcomes for persistent type II endoleaks with significant aneurysm sac growth.
Why the study?
Although treatment techniques for type II endoleak after EVAR have advanced, clinical outcomes remain unsatisfactory, requiring an understanding of current treatment status and limitations to guide optimal patient-tailored strategies.
Does embolization improve clinical outcomes in patients with Type II endoleak after endovascular abdominal aortic aneurysm repair?
Does embolization improve clinical outcomes in patients with Type II endoleak after endovascular abdominal aortic aneurysm repair?
While embolization techniques for Type II endoleak after EVAR have high technical success rates, long-term clinical outcomes remain unsatisfactory due to recurrent endoleaks, highlighting the need for patient-tailored treatment strategies.
Answers are grounded in this paper and cite their sources.
Embolization for persistent Type II endoleak warrants caution given unsatisfactory outcomes; leaves open need for tailored strategies and better evidence.
Type II endoleak is the most common complication after endovascular abdominal aortic aneurysm repair. Type II endoleak with aneurysm sac growth is not benign for long-term outcomes of endovascular abdominal aortic aneurysm repair and should be treated to prevent secondary stent graft-related complications and aneurysm rupture. The current consensus is to consider treatments for persistent type II endoleak with significant aneurysm sac growth. For complete embolization of type II endoleak to obliterate the endoleak cavity with the elimination of all supplying arteries, it is necessary to select and combine the treatment options. Although the treatment techniques for type II endoleak have advanced, clinical outcomes remain unsatisfactory. To overcome this clinical discrepancy, the optimal patient-tailored treatment strategy is required in clinical practice, with an understanding of the current status and limitations of treatment for type II endoleak.
No takes yet. Share an insight, caveat, or question.
Hiroki Horinouchi (2025) conducted a review in Type II endoleak after endovascular abdominal aortic aneurysm repair. Embolization and surgical treatments vs. Conservative management was evaluated. Treatments for persistent type II endoleak with significant aneurysm sac growth are necessary to prevent complications, though current clinical outcomes of embolization techniques remain unsatisfactory.
Synapse has enriched 10 related papers. Consider them for comparative context: